Superluminal Medicines (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Organizations Involved
- NVIDIA, Eli Lilly and Company
- Company Description
- Superluminal Medicines, Inc., 'The Membrane Company' using generative biology, chemistry, and machine learning approaches to revolutionize the speed and accuracy of how medicines are created.
- Market
- Pharmaceuticals
- Location
- Boston, MA, USA
- Coinvestors
- Insight Partners, NVentures, Gaingels, Catalio Capital Management, Eli Lilly and Company, Cooley LLP